Juvenile Arthritis Awareness Month

United States, Canada

About

Juvenile Arthritis Awareness Month is observed throughout July to raise awareness of juvenile arthritis, a group of autoimmune and inflammatory conditions that can affect children and teens. The observance highlights the challenges young people may face, including joint pain, stiffness, fatigue, and limitations in daily activities, while recognizing their strength, resilience, and determination.

Throughout the month, families, schools, healthcare professionals, and communities are encouraged to learn more about juvenile arthritis, support early diagnosis and effective treatment, and foster understanding for children living with the condition. It is also a meaningful opportunity to celebrate young advocates and remind those affected that they are not alone.

History

Juvenile Arthritis Awareness Month is observed throughout July to increase public understanding of arthritis and related rheumatic diseases affecting children and adolescents. Although arthritis is often associated with older adults, juvenile arthritis can begin during infancy, childhood, or the teenage years. The observance developed from the work of families, pediatric rheumatologists, patient organizations, and arthritis advocates who sought greater recognition of the physical, emotional, and educational challenges faced by young people with these conditions.

Its history is closely connected with the changing medical understanding of childhood arthritis. Earlier discussions often treated persistent joint inflammation in children as a relatively narrow condition, but physicians gradually recognized that juvenile arthritis includes several distinct forms, now commonly grouped under juvenile idiopathic arthritis. Advances in pediatric rheumatology improved diagnosis and helped distinguish inflammatory arthritis from injuries, infections, and other childhood illnesses. Over time, treatment also progressed from relying largely on symptom control to using disease-modifying medicines and biologic therapies intended to limit inflammation and protect long-term joint function.

As the observance evolved, its focus expanded beyond medical facts. July campaigns have encouraged earlier evaluation of symptoms such as ongoing joint swelling, stiffness, pain, fatigue, and reduced mobility. They have also highlighted the importance of coordinated support involving families, schools, health-care professionals, and community organizations. Education about accommodations, physical activity, mental health, and the social effects of living with a chronic condition has become an important part of the awareness effort.

Culturally, Juvenile Arthritis Awareness Month helps challenge the misconception that arthritis is exclusively an older person’s disease. It gives children and young adults living with juvenile arthritis greater visibility and affirms that their experiences deserve attention in pediatric health discussions. The month also provides an opportunity to recognize caregivers and advocates while promoting continued research into the causes, treatment, and long-term outcomes of juvenile arthritis.

Timeline

1897
British physician George Frederic Still published his description of a chronic joint disease in children, including the systemic form later commonly called Still's disease, a type of juvenile idiopathic arthritis.
1999
The U.S. Food and Drug Administration approved etanercept (Enbrel) for children with polyarticular-course juvenile rheumatoid arthritis, making it an early biologic treatment option for juvenile arthritis.
2008
The U.S. Food and Drug Administration approved abatacept (Orencia) for moderate-to-severe polyarticular juvenile idiopathic arthritis in children aged 6 years and older.
2011
The U.S. Food and Drug Administration approved tocilizumab (Actemra) for active systemic juvenile idiopathic arthritis in patients aged 2 years and older.
2013
The U.S. Food and Drug Administration approved canakinumab (Ilaris) for active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

Upcoming dates

Sources

Same day

Related